News
Eye drops Safety: Tips from an Ophthalmologist
Recent recalls of... Here goes the content ...
Blood protein signatures may predict ALS onset in genetically at-risk individuals years before symptoms appear. Researchers from the University of Miami Comprehensive Center for Brain Health shared 16 studies at AAIC 2026, highlighting advances in dementia treatment, blood-based biomarkers and early cognitive screening. A Sylvester-led study reveals how a rare mutation helps blood cancers evade BTK-targeted therapies and points toward strategies to prevent resistance. Miller School researchers found early Alzheimer’s-related damage in lab-grown intestinal tissue, revealing new clues about the gut-brain connection.
Blood Proteins May Predict When Genetically At-Risk People Develop ALS

University of Miami Researchers Showcase Advances in Dementia Detection, Treatment and Brain Health at AAIC 2026

Sylvester Comprehensive Cancer Center Study Reveals How Blood Cancers Outsmart BTK-Targeted Therapies

Could the Gut Hold Early Clues to Alzheimer’s Disease?






